198 related articles for article (PubMed ID: 31773277)
1. Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis.
Kanayama M; Mori M; Matsumiya H; Taira A; Shinohara S; Kuwata T; Imanishi N; Yoneda K; Kuroda K; Tanaka F
Surg Today; 2020 May; 50(5):469-474. PubMed ID: 31773277
[TBL] [Abstract][Full Text] [Related]
2. Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis.
Iwata T; Yoshida S; Nagato K; Nakajima T; Suzuki H; Tagawa T; Mizobuchi T; Ota S; Nakatani Y; Yoshino I
Surg Today; 2015 Oct; 45(10):1263-70. PubMed ID: 25412984
[TBL] [Abstract][Full Text] [Related]
3. Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis.
Iwata T; Yoshida S; Fujiwara T; Wada H; Nakajima T; Suzuki H; Yoshino I
Ann Thorac Surg; 2016 Dec; 102(6):1905-1910. PubMed ID: 27546601
[TBL] [Abstract][Full Text] [Related]
4. Perioperative pirfenidone treatment as prophylaxis against acute exacerbation of idiopathic pulmonary fibrosis: a single-center analysis.
Sekihara K; Aokage K; Miyoshi T; Tane K; Ishii G; Tsuboi M
Surg Today; 2020 Aug; 50(8):905-911. PubMed ID: 32144483
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study.
Furuya K; Sakamoto S; Shimizu H; Sekiya M; Kinoshita A; Isshiki T; Sugino K; Matsumoto K; Homma S
Respir Med; 2017 May; 126():93-99. PubMed ID: 28427556
[TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of pirfenidone combined with carboplatin-based chemotherapy in patients with idiopathic pulmonary fibrosis and non-small cell lung cancer: A retrospective cohort study.
Yamamoto Y; Yano Y; Kuge T; Okabe F; Ishijima M; Uenami T; Kanazu M; Akazawa Y; Yamaguchi T; Mori M
Thorac Cancer; 2020 Nov; 11(11):3317-3325. PubMed ID: 32986306
[TBL] [Abstract][Full Text] [Related]
8. Reduced incidence of lung cancer in patients with idiopathic pulmonary fibrosis treated with pirfenidone.
Miura Y; Saito T; Tanaka T; Takoi H; Yatagai Y; Inomata M; Nei T; Saito Y; Gemma A; Azuma A
Respir Investig; 2018 Jan; 56(1):72-79. PubMed ID: 29325685
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of combined corticosteroid and pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis after surgery for lung cancer: a case report.
Ohkubo H; Kunii E; Moriyama S; Niimi A
Respir Investig; 2015 Jan; 53(1):45-7. PubMed ID: 25542603
[No Abstract] [Full Text] [Related]
10. Uniportal video-assisted thoracic surgery and perioperative pirfenidone for lung cancer and idiopathic pulmonary fibrosis: a case report.
Saiki A; Mizobuchi T; Nagato K; Ishibashi F; Tsuyusaki J; Sugano I
J Int Med Res; 2021 Sep; 49(9):3000605211016998. PubMed ID: 34521243
[TBL] [Abstract][Full Text] [Related]
11. Preoperative use of pirfenidone and reduced risk of postoperative severe respiratory complications in patients with idiopathic pulmonary fibrosis: Propensity score-matched analysis using a nationwide database in Japan.
Urushiyama H; Jo T; Hasegawa W; Ando T; Sakamoto Y; Uda K; Matsui H; Fushimi K; Yasunaga H; Nagase T
Respirology; 2021 Jun; 26(6):590-596. PubMed ID: 33870611
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis.
Yoon HY; Kim DS; Song JW
Respiration; 2019; 97(3):242-251. PubMed ID: 30332670
[TBL] [Abstract][Full Text] [Related]
13. Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbation.
Vianello A; Molena B; Turato C; Braccioni F; Arcaro G; Paladini L; Andretta M; Saetta M
Curr Med Res Opin; 2019 Jul; 35(7):1187-1190. PubMed ID: 30612467
[No Abstract] [Full Text] [Related]
14. Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survival.
Tanaka S; Miyoshi K; Higo H; Kurosaki T; Otani S; Sugimoto S; Yamane M; Kiura K; Toyooka S; Oto T
Respir Investig; 2019 Mar; 57(2):165-171. PubMed ID: 30600175
[TBL] [Abstract][Full Text] [Related]
15. [Successful resection of lung cancer with idiopathic pulmonary fibrosis treated by pirfenidone during perioperative period].
Shomura S; Katayama Y; Kusagawa H; Komada T
Kyobu Geka; 2013 Sep; 66(10):890-3. PubMed ID: 24008638
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of pirfenidone in patients with advanced-stage idiopathic pulmonary fibrosis.
Sakamoto S; Itoh T; Muramatsu Y; Satoh K; Ishida F; Sugino K; Isobe K; Homma S
Intern Med; 2013; 52(22):2495-501. PubMed ID: 24240787
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study.
Harari S; Caminati A; Albera C; Vancheri C; Poletti V; Pesci A; Luppi F; Saltini C; Agostini C; Bargagli E; Sebastiani A; Sanduzzi A; Giunta V; Della Porta R; Bandelli GP; Puglisi S; Tomassetti S; Biffi A; Cerri S; Mari A; Cinetto F; Tirelli F; Farinelli G; Bocchino M; Specchia C; Confalonieri M
Respir Med; 2015 Jul; 109(7):904-13. PubMed ID: 25962649
[TBL] [Abstract][Full Text] [Related]
18. Composite Physiologic Index, Percent Forced Vital Capacity and Percent Diffusing Capacity for Carbon Monoxide Could Be Predictors of Pirfenidone Tolerability in Patients with Idiopathic Pulmonary Fibrosis.
Konishi S; Arita M; Ito I; Tachibana H; Takaiwa T; Fukuda Y; Watanabe N; Tsubouchi K; Masuda G; Tanaka M; Kourogi Y; Kunimasa K; Nishiyama A; Iwasaku M; Ito A; Tokioka F; Yoshioka H; Hashimoto T; Ishida T
Intern Med; 2015; 54(22):2835-41. PubMed ID: 26567995
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Behr J; Bendstrup E; Crestani B; Günther A; Olschewski H; Sköld CM; Wells A; Wuyts W; Koschel D; Kreuter M; Wallaert B; Lin CY; Beck J; Albera C
Lancet Respir Med; 2016 Jun; 4(6):445-53. PubMed ID: 27161257
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: a case-control study.
Sakamoto S; Muramatsu Y; Satoh K; Ishida F; Kikuchi N; Sano G; Sugino K; Isobe K; Takai Y; Homma S
Respirology; 2015 Apr; 20(3):445-52. PubMed ID: 25639750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
